Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
St. Jude Children's Research Hospital Lance Armstrong Foundation |
---|---|
Information provided by: | St. Jude Children's Research Hospital |
ClinicalTrials.gov Identifier: | NCT00186992 |
Researchers at St. Jude Children's Research Hospital are looking for more effective ways to deliver radiation therapy to pediatric tumors of the bone and soft tissues. The goal of the study is to improve local control of musculoskeletal tumors with image-guided radiation therapy (IGRT) while minimizing radiation related side effects. IGRT uses computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET) images to precisely define tumor location and to carefully plan radiation treatment. This approach allows doctors to deliver highly conformal radiation therapy to the tumor while protecting nearby healthy normal tissues.
Condition | Intervention | Phase |
---|---|---|
Sarcoma, Ewing's Rhabdomyosarcoma Soft Tissue Sarcoma Musculoskeletal Tumors |
Procedure: Delivery of conformal limited margin radiotherapy |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-Related Treatment Effects |
Estimated Enrollment: | 210 |
Study Start Date: | January 2003 |
Estimated Study Completion Date: | December 2010 |
Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1
Eligible patients will be accessioned at the time of irradiation and undergoo a pre-radiotherapy evaluation, treatment planning, image-guided radiotherapy delivery and intra-and post-irradiation evaluations.
|
Procedure: Delivery of conformal limited margin radiotherapy
Conformal limited image radiotherapy is radiation therapy that targets tumors with a prescribed dose of radiation which allows the surrounding normal tissues to remain basically untreated.
|
Ages Eligible for Study: | up to 25 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Contact: Matthew Krasin, MD | 866-278-5833 | info@stjude.org |
United States, Tennessee | |
St. Jude Children's Research Hospital | Recruiting |
Memphis, Tennessee, United States, 38105 | |
Contact: Matthew Krasin, MD 866-278-5833 info@stjude.org | |
Principal Investigator: Matthew Krasin, MD |
Principal Investigator: | Matthew Krasin, MD | St. Jude Children's Research Hospital |
Responsible Party: | St. Jude Children's Research Hospital ( Matthew Krasin, MD/Principal Investigator ) |
Study ID Numbers: | RTSARC |
Study First Received: | September 12, 2005 |
Last Updated: | December 2, 2008 |
ClinicalTrials.gov Identifier: | NCT00186992 |
Health Authority: | United States: Institutional Review Board |
Sarcoma radiation therapy Other musculoskeletal tumors |
Neoplasms, Connective and Soft Tissue Ewing's sarcoma Sarcoma, Ewing's Malignant mesenchymal tumor Sarcoma |
Osteosarcoma Osteogenic sarcoma Soft tissue sarcomas Rhabdomyosarcoma |
Neoplasms, Muscle Tissue Neoplasms Neoplasms, Bone Tissue |
Neoplasms by Histologic Type Myosarcoma Neoplasms, Connective Tissue |